# NK Cell Deregulation in HBV Patients

> **NCT03761875** · NA · UNKNOWN · sponsor: **University Hospital, Limoges** · enrollment: 80 (estimated)

## Conditions studied

- Hepatitis B Virus

## Interventions

- **OTHER:** blood sample CHB patients
- **OTHER:** boold sample Control group

## Key facts

- **NCT ID:** NCT03761875
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-11
- **Primary completion:** 2023-12
- **Final completion:** 2024-03
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03761875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03761875, "NK Cell Deregulation in HBV Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03761875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*